DIAGNOSTIC AND PROGNOSTIC METHOD FOR MYELOFIBROSIS

摘要

The present invention generally relates to a MPNs marker and particularly to a biomarker associated with MF. The present invention provides a method for diagnosis, prognosing or staging MPNs, in particular PMF, by measuring a specific marker. Accordingly, a first aspect of the present invention relates to an assay method for the detection and quantification of the levels of EDA FN in a biological sample. Moreover, a second aspect of the present invention relates to a method for diagnosis, prognosing or staging MF in a living subject based on the measured levels of EDA FN.